Lorence H. Kim, Director at Revolution Medicines, Inc. (RVMD), sold 56,000 shares at $200.56 ($11.4M) on 2026-08-31, disclosed to the SEC on 2026-09-02.
Scheduled sale ($11.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $200.56 | 300 | $60K | 0.5% |
| 2 | $201.47 | 6,597 | $1.3M | 11.7% |
| 3 | $202.48 | 12,919 | $2.6M | 23.0% |
| 4 | $203.55 | 26,160 | $5.3M | 46.8% |
| 5 | $204.35 | 7,271 | $1.5M | 13.1% |
| 6 | $205.19 | 2,128 |
| $437K |
| 3.8% |
| 7 | $206.15 | 625 | $129K | 1.1% |
| Total | $203.24 avg | 56,000 | $11.4M | 100% |
| Filing → |
| COWN | BUY | 2022-02-28 | $901K | — | Filing → |
| MRNA | SELL | 2020-06-04 | $14.1M | — | Filing → |
| MRNA | SELL | 2020-06-04 | $166K | — | Filing → |